Posts by cstephenson@legacymedsearch.com
Digital Surgery’s AI Platform Will Guide Surgical Teams Through Complex Procedures
Digital Surgery, a health tech company shaping the future of surgery through the convergence of surgical expertise and technology, today announced it has developed and successfully demonstrated the world’s first real-time, dynamic artificial intelligence (AI) system designed for the operating room (OR). The company is building the data to power the future of surgery through…
Read MoreInnovative Bedside Biologic Maker RedDress Receives 510(k) for RD1 System
RedDress Ltd announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its RD1 system. RD1 is an innovative wound care product which enables health care providers to produce in real time, in vitro whole blood clots, for use as a chronic wound care product. It has been developed to…
Read MoreFirst Ever Color X-Ray Performed on a Human
What if, instead of a black and white X-ray picture, a doctor of a cancer patient had access to colour images identifying the tissues being scanned? This colour X-ray imaging technique could produce clearer and more accurate pictures and help doctors give their patients more accurate diagnoses. This is now a reality, thanks to a…
Read MoreImplantable Organ Developer Miromatrix Raises Additional $15.7M in Series B Funding
July 12, 2018 – Press Release by Miromatrix Medical Miromatrix Medical Inc. is excited to announce it recently raised $15.7 million in Series B-2 funding, surpassing its goal of $10 million. As part of the round, Miromatrix also welcomed its first large strategic investor, a multibillion-dollar health care company. The additional funding supports the company’s…
Read MoreOnkos Surgical and Insight Medical Systems Team Up On an Augmented Reality Surgical System
Insight Medical Systems has teamed up with Onkos Surgical, Inc. to explore opportunities to apply Insight Medical’s ARVIS™ (Augmented Reality Visualization and Information System) in musculoskeletal oncology. The companies are working on a pilot project to assess the technology for use in tumor surgery. ARVIS™, currently under development, has tracking and visualization capabilities which allow precise and efficient…
Read MoreImaging Group MITA Warns China Tariffs Will Cost $138M to US Imaging Industry
The Medical Imaging and Technology Alliance (MITA) – the leading organization and collective voice of medical imaging equipment, radiopharmaceutical manufacturers, innovators, and product developers – today called on the Trump Administration to establish a timely and robust exemption process for medical imaging products and components from China Section 301 tariffs, which went into effect today.…
Read MoreAxonics Receives CE Mark for Sacral Neuromodulation External Trial System
Axonics Modulation Technologies, Inc., developer of the first rechargeable Sacral Neuromodulation (r-SNM™) system for the treatment of urinary and bowel dysfunction, announced today that it has received the CE mark for its Sacral Neuromodulation External Trial System. Axonics received CE mark in June 2016 for its miniaturized implantable neurostimulator, tined lead, programmers, charger and related accessories. The External Trial System…
Read MoreFDA Clearance for Embolx’s Next Gen Sniper Balloon Occlusion Microcatheter
Embolx, Inc., a medical device company developing microcatheters for arterial embolization procedures, today announced that the company has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its next generation family of Sniper® Balloon Occlusion Microcatheters, an innovative system for pressure-directed arterial embolization therapy. Now commercially available in the United States,…
Read MoreBreath Biopsy Platform Wins UK’s Most Prestigious Award for Innovative Engineering
Owlstone Medical, a diagnostics company developing a breathalyzer for disease, has announced the team behind the Company’s unique Breath Biopsy® platform has been named the winner of the MacRobert Award 2018 by the Royal Academy of Engineering. Owlstone Medical’s Breath Biopsy platform, including the ReCIVA Breath Sampler, has opened up the potential for earlier diagnosis…
Read MoreBoston Scientific to Pay $202 Million for Cryterion Medical
Boston Scientific Corporation today announced a definitive agreement to acquire Cryterion Medical, Inc., a privately-held company developing a single-shot cryoablation platform for the treatment of atrial fibrillation (AF). The addition of this cryoballoon platform positions the company as the first to have both cryothermal and radiofrequency (RF) single-shot, balloon-based ablation therapies in its portfolio. Boston…
Read More